×
About 1,132 results

ALLMedicine™ Hepatitis D Center

Research & Reviews  537 results

Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral t...
https://doi.org/10.1111/liv.14740
Liver International : Official Journal of the International Association for the Study of the Liver; Bremer B, Anastasiou O et. al.

Nov 20th, 2020 - The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analyzed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al., Lancet Infectious Diseases 2019) with the Robogene assay (RA; ...

The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappr...
https://doi.org/10.1111/liv.14729
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Rizzetto M, Hamid S

Nov 12th, 2020 - Although hepatitis D is believed to be an important medical problem in Africa and many areas of Asia, the geographical distribution and prevalence rates of infection with the hepatitis D virus (HDV) vary considerably, are often inconsistent and so...

Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
https://doi.org/10.14309/ajg.0000000000000954
The American Journal of Gastroenterology; Da BL, Rahman F et. al.

Oct 7th, 2020 - The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. A study of North American patients with hepatitis B (HBV) referred to the NIH...

Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.
https://doi.org/10.1111/liv.14677
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Giersch K, Hermanussen L et. al.

Sep 30th, 2020 - As a result of the limited availability of in vivo models for hepatitis D virus (HDV), treatment options for HDV chronically infected patients are still scant. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as HDV entry rec...

Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410281
PloS One; Cabezas C, Trujillo O et. al.

Aug 7th, 2020 - In 1991, Peru launched the first vaccination program against hepatitis B in children aged under 5 years in the hyperendemic [hepatitis B virus (HBV) and hepatitis D virus (HDV)] province of Abancay. We conducted a cross-sectional study to determin...

see more →

Clinicaltrials.gov  567 results

Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral t...
https://doi.org/10.1111/liv.14740
Liver International : Official Journal of the International Association for the Study of the Liver; Bremer B, Anastasiou O et. al.

Nov 20th, 2020 - The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analyzed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al., Lancet Infectious Diseases 2019) with the Robogene assay (RA; ...

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappr...
https://doi.org/10.1111/liv.14729
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Rizzetto M, Hamid S

Nov 12th, 2020 - Although hepatitis D is believed to be an important medical problem in Africa and many areas of Asia, the geographical distribution and prevalence rates of infection with the hepatitis D virus (HDV) vary considerably, are often inconsistent and so...

Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
https://doi.org/10.14309/ajg.0000000000000954
The American Journal of Gastroenterology; Da BL, Rahman F et. al.

Oct 7th, 2020 - The American Association for the Study of Liver Diseases recommends hepatitis D virus (HDV) screening in certain high-risk groups; however, the effectiveness is unknown. A study of North American patients with hepatitis B (HBV) referred to the NIH...

Murine hepatocytes do not support persistence of Hepatitis D virus mono-infection in vivo.
https://doi.org/10.1111/liv.14677
Liver International : Official Journal of the International Association for the Study of the Liver REFERENCES; Giersch K, Hermanussen L et. al.

Sep 30th, 2020 - As a result of the limited availability of in vivo models for hepatitis D virus (HDV), treatment options for HDV chronically infected patients are still scant. The discovery of sodium taurocholate cotransporting polypeptide (NTCP) as HDV entry rec...

see more →

News  27 results

Risk Factors Can Help Spot People Who Need Hep D Screening
https://www.medscape.com/viewarticle/940855

Nov 12th, 2020 - NEW YORK (Reuters Health) - Several risk factors associated with hepatitis D virus (HDV) infection can be used to identify people who should be screened, researchers report. "It was interesting to find that the risk factors that were identified in...

Hepatitis D Virus Coinfection Boosts HBV Healthcare Costs
https://www.medscape.com/viewarticle/922853

Dec 19th, 2019 - NEW YORK (Reuters Health) - Hepatitis delta virus (HDV) infection, which occurs only as a co-infection with acute hepatitis B (HBV) or a superinfection with chronic HBV, is associated with higher healthcare utilization and costs than HBV alone, a ...

HDV combo therapy reduces viral loads
https://www.mdedge.com/gihepnews/article/211868/hepatology/hdv-combo-therapy-reduces-viral-loads?channel=346
Will Pass, MDedge News

Nov 8th, 2019 - BOSTON – For most patients with chronic hepatitis D virus (HDV) infection, combination therapy with lonafarnib, ritonavir, and peginterferon may significantly decrease viral loads, based on interim results from the phase IIa LIFT trial. After 6 mo.

Viral Hepatitis Overview: Osmosis Study Video
https://www.medscape.com/viewarticle/895006

Apr 19th, 2018 - What is the hepatitis virus? Well, the hepatitis virus invades liver cells and causes inflammation in the liver tissue. Five hepatitis viruses are recognized: hepatitis A, hepatitis B, hepatitis C, hepatitis D, and hepatitis E. They all have sligh...

In reply: Acute liver failure
https://www.mdedge.com/ccjm/article/110841/hepatology/reply-acute-liver-failure?channel=164
Tavankit Singh, MD, Nancy Gupta, MD et. al.

Aug 1st, 2016 - In Reply: We thank Dr. Homler for bringing hepatitis D as a potential cause of acute liver failure to our attention.

see more →

Patient Education  1 results see all →